U.S. pharma giant copyright scrapped two experimental weight loss capsules last 12 months—a once-every day capsule, lotiglipron, because of elevated liver enzymes plus a twice-every day tablet, danuglipron, as a result of solid Negative effects—but CEO Albert Bourla has said the company is determined to “Enjoy and acquire” inside the obesit